The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 200.00
Bid: 202.00
Ask: 203.00
Change: 1.00 (0.50%)
Spread: 1.00 (0.495%)
Open: 199.50
High: 203.00
Low: 199.50
Prev. Close: 199.00
JHD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Chairman’s Statement to the Annual General Meeting

1 Dec 2022 07:00

RNS Number : 1121I
James Halstead PLC
01 December 2022
 

 

1 December 2022

JAMES HALSTEAD PLC

(the 'Group')

 

Chairman's Statement to the Annual General Meeting

 

James Halstead plc, the commercial flooring company, is holding its 107th AGM today at 12.00 pm at which the Chairman, Mr Anthony Wild, will make the following statement:

 

"Firstly, let me welcome you all to our AGM in a return to our traditional face to face meeting. Customarily, I give a short update on trading for the first few months of our financial year but with markets and economies facing many issues I feel a longer update is appropriate.

 

As announced at our full year results on 3 October 2022, we took the decision to increase our levels of stockholdings as cost and supply pressures continued to affect our global markets. This decision was taken in order to mitigate future energy cost increases and potential raw material supply shortages. It was also noted that, in the event the crisis did not escalate, it was likely that we would need to suspend some production for a period.

 

Turning to the current trading, on the positive side, our confidence in the resilience of commercial flooring continues and in most markets sales are ahead of this stage last year. During this same period we have also seen our stock levels reduce by over 10%. Additionally, it has been a mild autumn and the energy crisis has not further escalated. International shipping rates have started to reduce and availability of shipping has improved. We anticipate that shipping rates will remain lower in the near-to-mid term. Moreover, the fall in the value of Sterling has offered a competitive advantage in exports.

 

The adverse effects of the energy crisis on our supply of key materials from Europe has not hit our supply chain, as yet, but this was always a key risk for the winter and remains so.

 

I must note, unfortunately, that some production lines in Radcliffe have been affected by strike action by a section of the workforce and for several weeks have, to a large extent, not produced. This has not affected sales to any significant extent but has lessened our ability to take up some project opportunities in overseas markets that would have required a fast response in manufacturing.

 

Energy costs have significantly increased over the past year and the cost of energy to us, as a manufacturer, are very significant. To put this in context, the energy costs at the Radcliffe site are (in the four months to 31 October 2022) more than double the costs of the comparative period last year, despite this year having eight weeks less production. Whilst support from the Government on wholesale prices to business is welcome, our energy costs have yet to hit the cap at which Government's support would be payable and even then add on costs to wholesale prices are around an additional 40% charge and are outside the scope of assistance.

 

These are very challenging times, especially here in the UK, and we have tasked our teams to monitor costs and minimise cash outflows as high inflation lingers. In the short term, and against this current climate, there has obviously been margin erosion and we continue to pass on cost increases, as much as possible. In addition, as noted above, commercial flooring demand is robust.

 

There are challenges across our global markets but it is still early in our financial year and historically the second half of our financial year is our stronger.

 

I and the Board remain cautiously positive about the medium term prospects for the Group as a whole."

 

- Ends -

 

Enquiries:

 

James Halstead:

 

Mark Halstead, Chief Executive

Telephone: 0161 767 2500

Gordon Oliver, Finance Director

 

 

 

Hudson Sandler:

 

Nick Lyon

Telephone: 020 7796 4133

Nick Moore

 

 

Panmure Gordon (NOMAD & Joint Broker):

 

Dominic Morley

Telephone: 020 7886 2500

 

WH Ireland (Joint Broker):

 

Ben Thorne

Telephone: 020 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMWPGBCGUPPGPU
Date   Source Headline
8th Apr 20244:54 pmRNSPDMR Exercise of Share Options
3rd Apr 20242:00 pmRNSPDMR Acquisition of Shares
28th Mar 202412:00 pmRNSPDMR Grant of Share Options
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:30 pmRNSAppointment of Senior Independent Director
31st Jan 20247:00 amRNSTrading Update
4th Jan 20244:34 pmRNSBoard Changes
1st Dec 20232:25 pmRNSResults of Annual General Meeting
1st Dec 20237:00 amRNSAGM Statement
17th Nov 202311:13 amRNSPDMR Grant of Share Options
10th Nov 20234:45 pmRNSBlock Listing Six Monthly Return
10th Nov 20234:43 pmRNSBlock Listing Six Monthly Return
13th Oct 202312:00 pmRNSPosting of Annual R&A and Notice of AGM
2nd Oct 20237:00 amRNSPreliminary Results
1st Aug 20237:00 amRNSTrading Update
31st Mar 20231:57 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSInterim Results
2nd Feb 20237:00 amRNSTrading Update
1st Dec 20224:36 pmRNSResults of Annual General Meeting
1st Dec 20227:00 amRNSChairman’s Statement to the Annual General Meeting
14th Oct 20225:46 pmRNSPosting of Annual R&A and Notice of AGM
3rd Oct 20227:00 amRNSPreliminary Results
14th Sep 20221:01 pmRNSNotice of Preliminary Results
16th Aug 20223:59 pmRNSPDMR Exercise of Share Options
10th Aug 20224:00 pmRNSPDMR Grant of Share Options
1st Aug 20227:00 amRNSTrading Update
13th Jul 202211:24 amRNSBlock Listing Six Monthly Return
5th May 202210:48 amRNSTR-1: Notification of Major Holdings
31st Mar 20227:00 amRNSInterim Results
1st Feb 20227:00 amRNSTrading Update
17th Jan 202211:00 amRNSTotal Voting Rights and Application for Listing
13th Jan 20222:50 pmRNSApplication for Bonus Shares
7th Jan 20229:36 amRNSBlock Listing Six Monthly Return
7th Jan 20229:32 amRNSTotal Voting Rights
18th Nov 202111:13 amRNSResults of Annual General Meeting
18th Nov 20217:00 amRNSChairman’s Statement to the Annual General Meeting
15th Oct 20214:00 pmRNSPosting of Annual R&A and Notice of AGM
4th Oct 20217:00 amRNSPreliminary Results
20th Sep 20212:46 pmRNSNotice of Preliminary Results
4th Aug 20217:00 amRNSTrading Update
14th Jul 20215:00 pmRNSBlock Listing Six Monthly Return
25th Jun 20214:35 pmRNSPrice Monitoring Extension
22nd Jun 20214:00 pmRNSPDMR Exercise of Share Options
31st Mar 20217:00 amRNSInterim Results
1st Feb 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSBlock Listing Six Monthly Return
12th Nov 202011:00 amRNSResults of Annual General Meeting
12th Nov 20207:00 amRNSChairman's Statement to the Annual General Meeting
16th Oct 20204:00 pmRNSPosting of Annual Report and Notice of AGM
1st Oct 20207:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.